Inner Sidebar Right

BC-043 Director of Community Outreach, Debra Melamed speaks with Regional Sales Director of Foundation Medicine, Amy Macalintal about their comprehensive genomic profiling tests

BC-043 Director of Community Outreach, Debra Melamed speaks with Regional Sales Director of Foundation Medicine, Amy Macalintal about their comprehensive genomic profiling tests

2018 - 10 - 16

These tests are for people with a cancer diagnosis that are considering chemotherapy, have had traditional treatment that has failed them, or for someone who has had a reoccurrence. Their tests detect genomic alterations on cancer tumor cells’ DNA. They help your doctor to identify more potential treatment options than other available tests because they analyze all genes known to be relevant in human cancers. The test report includes the identified genomic alterations and provides information on which targeted therapies, immunotherapies, or clinical trials are a match.

This personalized approach makes getting the right treatment for your personal cancer possible, saving patients time, money, and the repercussions of negative side-effects from broad-based treatments.

They offer 3 different test that must be ordered by your doctor, FoundationOne Heme (for leukemia, lymphoma, and myeloma), FoundationACT (liquid biopsy when a tissue biopsy is not possible), and FoundationOne Cdx (primarily for non-small-cell lung, breast, prostate, colorectal, melanoma, and ovarian cancers)

For more information go to www.foundationmedicine.com.
 
You can learn more about this test and others by taking the Cancer Free University Course. It is 50% through this link https://beatcancer.org/blog-posts/cancer-free-university-course.

 

Subscribe on Iunes

Join the conversation. Create a topic in our forum.


Please Support Us

THROUGH amazon

Connect with Us

Free Download

Join Our Health E-News Community Free Download of Top 12 Fruits and Vegetables to Only Eat Organic.